M Y Shapira
Overview
Explore the profile of M Y Shapira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shapira M, Klimov A, Sheth V, Grisariu S, Avni B, Or R, et al.
Bone Marrow Transplant
. 2021 Nov;
56(12):3109.
PMID: 34759329
No abstract available.
2.
Shapira M, Klimov A, Vipul S, Grisariu S, Avni B, Or R, et al.
Bone Marrow Transplant
. 2017 Jun;
52(10):1416-1422.
PMID: 28650453
GvHD results in death in the majority of steroid-resistant patients. This report assesses the safety and efficacy of two regional intra-arterial steroid (IAS) treatment protocols in the largest published cohort...
3.
Tsirigotis P, Resnick I, Avni B, Grisariu S, Stepensky P, Or R, et al.
Bone Marrow Transplant
. 2014 Jul;
49(11):1389-92.
PMID: 25068424
The incidence and outcome of moderate-to-severe veno-occlusive (VOD) disease was analyzed in 271 consecutive patients with hematological malignancies who underwent allogeneic SCT (allo-SCT) using the same reduced intensity regimen (RIC)....
4.
Averbuch D, Horwitz E, Strahilevitz J, Stepensky P, Goldschmidt N, Gatt M, et al.
Infection
. 2013 May;
41(5):991-7.
PMID: 23653428
Purpose: Colistin is increasingly used as the last-resort treatment option against infections caused by multidrug-resistant (MDR) Gram-negative pathogens, but its nephrotoxicity is of concern, especially in severely ill patients. The...
5.
Elad S, Zadik Y, Yarom N, Or R, Shapira M
Oral Dis
. 2013 Jan;
19(5):530.
PMID: 23279619
No abstract available.
6.
Tsirigotis P, Shapira M, Or R, Bitan M, Samuel S, Gesundheit B, et al.
Bone Marrow Transplant
. 2009 Dec;
45(7):1189-96.
PMID: 19946341
The influence of graft composition on the outcome of reduced-intensity (RIC) allogeneic PBSC transplantation (allo-PBSC) remains controversial. In this study, we analyzed the impact of CD34+ cell dose on the...
7.
Gesundheit B, Budowski E, Israeli M, Shapira M, Resnick I, Bringer R, et al.
Bone Marrow Transplant
. 2009 Sep;
45(3):527-33.
PMID: 19718067
After allogeneic hematopoietic SCT (alloHSCT), immunosuppressed patients are susceptible to opportunistic infections, and uncontrolled function of the graft can result in GVHD. Accurate immune monitoring may help early detection and...
8.
Kristt D, Gesundheit B, Stein J, Shapira M, Or R, Amar A, et al.
Bone Marrow Transplant
. 2009 Jun;
45(1):137-47.
PMID: 19503109
Despite therapeutic advantages, double-donor (DD) HSCTs present technical problems for molecular chimerism (CHM) monitoring. These DD chimeras contain three matched DNAs, so that the genomes of donor(s) and recipient often...
9.
Shapira M, Abdul-Hai A, Resnick I, Bitan M, Tsirigotis P, Aker M, et al.
Bone Marrow Transplant
. 2008 Oct;
43(4):339-43.
PMID: 18850020
Alefacept (Amevive) is an immunosuppressive dimeric fusion protein that is used for psoriasis control. We recently showed its effect in acute steroid-resistant/dependent GVHD. In this study, we describe the effect...
10.
Tsirigotis P, Sella T, Shapira M, Bitan M, Bloom A, Kiselgoff D, et al.
Haematologica
. 2007 Nov;
92(11):e106-10.
PMID: 18024386
Androgens widely used in the treatment of bone marrow failure syndromes can in rare cases cause hepatic peliosis, a pathological entity characterized by multiple blood-filled cavities in the liver parenchyma....